Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jean Marie Pesola, Ph.D.

Co-Author

This page shows the publications co-authored by Jean Pesola and Donald Coen.
Connection Strength

2.526
  1. In vivo fitness and virulence of a drug-resistant herpes simplex virus 1 mutant. J Gen Virol. 2007 May; 88(Pt 5):1410-1414.
    View in: PubMed
    Score: 0.354
  2. Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production. J Virol. 2005 Dec; 79(23):14516-25.
    View in: PubMed
    Score: 0.321
  3. Human Cytomegalovirus Nuclear Egress Complex Subunit, UL53, Associates with Capsids and Myosin Va, but Is Not Important for Capsid Localization towards the Nuclear Periphery. Viruses. 2022 02 26; 14(3).
    View in: PubMed
    Score: 0.247
  4. A Role for Myosin Va in Human Cytomegalovirus Nuclear Egress. J Virol. 2018 03 15; 92(6).
    View in: PubMed
    Score: 0.187
  5. Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia. J Virol. 2017 Jan 15; 91(2).
    View in: PubMed
    Score: 0.173
  6. Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex. J Virol. 2015 Jan; 89(1):523-34.
    View in: PubMed
    Score: 0.149
  7. A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe. 2014 Apr 09; 15(4):446-56.
    View in: PubMed
    Score: 0.143
  8. Roles of conserved residues within the pre-NH2-terminal domain of herpes simplex virus 1 DNA polymerase in replication and latency in mice. J Gen Virol. 2014 Apr; 95(Pt 4):940-947.
    View in: PubMed
    Score: 0.141
  9. Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection. J Virol. 2014 Feb; 88(4):2337-9.
    View in: PubMed
    Score: 0.140
  10. Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress. J Virol. 2013 May; 87(9):5019-27.
    View in: PubMed
    Score: 0.132
  11. A mutation deleting sequences encoding the amino terminus of human cytomegalovirus UL84 impairs interaction with UL44 and capsid localization. J Virol. 2012 Oct; 86(20):11066-77.
    View in: PubMed
    Score: 0.127
  12. Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia. Virology. 2011 Sep 01; 417(2):239-47.
    View in: PubMed
    Score: 0.119
  13. Regulation of host and virus genes by neuronal miR-138 favours herpes simplex virus 1 latency. Nat Microbiol. 2021 05; 6(5):682-696.
    View in: PubMed
    Score: 0.057
  14. Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function. Sci Adv. 2020 04; 6(17):eaax9856.
    View in: PubMed
    Score: 0.054
  15. Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity. Sci Transl Med. 2019 04 10; 11(487).
    View in: PubMed
    Score: 0.051
  16. CCCTC-Binding Factor Acts as a Heterochromatin Barrier on Herpes Simplex Viral Latent Chromatin and Contributes to Poised Latent Infection. mBio. 2018 02 06; 9(1).
    View in: PubMed
    Score: 0.047
  17. Neuronal IFN signaling is dispensable for the establishment of HSV-1 latency. Virology. 2016 10; 497:323-327.
    View in: PubMed
    Score: 0.042
  18. A Herpesviral Lytic Protein Regulates the Structure of Latent Viral Chromatin. mBio. 2016 05 17; 7(3).
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.